Trial | NCT00596791  Report issue

Official Title

Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    tafluprost ...

  • Study Participants

    150
The purpose of this study is to investigate if changes in ocular signs and symptoms occur in patients with ocular hypertension or glaucoma when they switch from latanoprost 0.005% (Xalatan) to preservative free Tafluprost eye drops.
Study Started
Jan 31
2008
Primary Completion
Jul 31
2008
Study Completion
Aug 31
2008
Last Update
Jan 12
2009
Estimate

Drug tafluprost

prostaglandine analoque

1 arm Other

Open-lable study with one arm.

Criteria 

Inclusion Criteria:

Patients with a diagnosis of ocular hypertension or open angle glaucoma for which the patient has been using latanoprost 0.005% as his/her prior medication. - Evaluable patients must have ocular surface related symptoms and/or signs with their prior medication.
No Results Posted